Registry

Axon Quality Measures

Below is the list of quality measures in the Axon Registry®. They are listed in alphabetical order by disease state. MIPS requires that participants submit data for at least six measures, including at least one outcome or, if unavailable, a high-priority measure. For more information about AAN measure creation please visit our Quality Measures webpage

Measure names are linked to the associated specificiations where you can find all of the measure details.

Measure Details 
Axon Number CMS Assigned Number Disease State Measure Name CMS Designated Measure Type Eligible for MIPS Submission in 2018 via Axon
35 QPP 386 ALS Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences Process/High Priority Yes
32.1 AAN18 Child Neurology First Line Treatment for Intantile Spasms (IS)  Process Yes
33.1 AAN20 Child Neurology Querying for co-morbid conditions of tic disorder (TD) and Tourette Syndrome (TS) (Follow up added) Process Yes
34 AAN19 Child Neurology Botulinum Toxin Serotype A (BoNT-A) for Spasticity or Dystonia  Process Yes
16A QPP 318 Cross-Cutting Falls: Screening for Future Fall Risk High Priority Yes
16B QPP 154 Cross-Cutting Falls: Risk Assessment High Priority Yes
16C QPP 155 Cross-Cutting Falls: Plan of Care High Priority Yes
17 QPP 130 Cross-Cutting Documentation of Current Medications in the Medical Record High Priority Yes
18 QPP 047 Cross-Cutting Advanced Care Plan High Priority Yes
19 QPP 374 Cross-Cutting Closing the Referral Loop: Receipt of Specialist Report High Priority Yes
40.1 AAN15 Cross-Cutting Quality of Life Assessment (Patient Reported Outcome) Process Yes
08 N/A Dementia Staging of Dementia Process No
09 QPP 282 Dementia Dementia: Functional Status Assessment Process Yes
10 N/A Dementia Dementia: Screening for Depressive Symptoms Process No
30 QPP 288 Dementia Dementia: Caregiver Education and Support Process/High Priority Yes
31 QPP 286 Dementia Dementia: Counseling Regarding Safety Concerns Process/High Priority Yes
42 QPP 370 Depression Depression Remission at Twelve Months (Patient Reported Outcome) Outcome Yes
11 AAN1 DSP Diabetes/Pre-Diabetes Screening for Patients with DSP Process/High Priority Yes
26.1 AAN2 DSP DSP Screening for Unhealthy Alcohol Use (Follow up and annual screening added) Process Yes
01 N/A Epilepsy Seizure Frequency (Paired Measures with 02) Process No
02 N/A Epilepsy Etiology, Seizure Type, or Epilepsy Syndrome (Paired Measures with 01) Process No
03 AAN4 Epilepsy Screening for Psychiatric or Behavioral Health Disorders Process/ High Priority Yes
20 QPP 268 Epilepsy Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy Process Yes
41 AAN12 Epilepsy Quality of Life Assessment for Patients with Epilepsy (Patient Reported Outcome) Outcome Yes
36 N/A Essential Tremor Annual Assessment of Essential Tremor Severity Process No
07.1 AAN10 Falls Falls Screening (Aggregation of AAN Disease Specific Fal Measure) (Follow up added) Process/ High Priority Yes
 13  AAN5  Headache Medication Prescribed for Acute Migraine Attack Process  Yes
 15 QPP 435 Headache  Quality of Life Assessment for Patients with Primary Headache Disorder Outcome  Yes
 22 QPP 419  Headache Overuse of Neuroimaging For Patients with Primary Headache and a Normal Neurological Examination Process/High Priority  Yes
 25  AAN11  Headache Overuse of Barbiturate and Opioid Containing Medications for Primary Headache Disorders  Process  Yes
23 AAN8 Multiple Sclerosis Exercise and Appropriate Physical Activity Counseling for Patients with MS Process Yes
37.1 AAN14 Multiple Sclerosis Current MS Disability Scale Score (Follow up added) Process Yes
38 IRIS22 Ophthalmology Giant Cell Arteritis: Absence of Fellow Eye Involvement After Corticosteroid Treatment Outcome Yes
39 IRIS21 Ophthalmology Ocular Myasthenia Gravis: Improvement of Ocular Deviation or Absence of Diplopia or Functional Improvement Outcome Yes
04 QPP 290 Parkinson's Parkinson's Disease: Psychiatric Symptoms Assessment for Patients with Parkinson's Disease Process Yes
05 N/A Parkinson's Querying About Sleep Disturbance for Patients with Parkinson's Disease Process No
06.1 AAN9 Parkinson's Querying About Symptoms of Autonomic Dysfunction for Patients with Parkinson's Disease (Follow up added) Process Yes
27 QPP 291 Parkinson's Parkinson's Disease: Cognitive Impairment or Dysfunction Assessment Process Yes
28.1 AAN16 Parkinson's  Falls Outcome for Patients with Parkinson's Disease  Outcome Yes
29 QPP 293 Parkinson's Parkinson's Disease: Rehabilitative Therapy Options Process/High Priority Yes
24 QPP 276 Sleep Sleep Apnea: Assessment of Sleep Symptoms Process Yes